Non-invasive quantitative chemical measurements of liposomal formulations using Raman spectroscopy†

Elizabeth J. Legge, Ryan T. Coones, William A. Lee, Yiwen Pei, Natalie A. Belsey and Caterina Minelli
{"title":"Non-invasive quantitative chemical measurements of liposomal formulations using Raman spectroscopy†","authors":"Elizabeth J. Legge, Ryan T. Coones, William A. Lee, Yiwen Pei, Natalie A. Belsey and Caterina Minelli","doi":"10.1039/D4PM00238E","DOIUrl":null,"url":null,"abstract":"<p >With a growing interest towards low batch-volume personalised medicines and continuous manufacturing of pharmaceuticals, the need for robust non-invasive quality control analytical methods is becoming increasingly important. Current methods for the quantification of total and encapsulated drug in a liposomal formulation include reversed-phase high-performance liquid chromatography with ultraviolet or fluorescence spectroscopy, which requires sample consumption after procedures such as ultrafiltration to separate the free drug from the encapsulated drug. We have developed and tested a method to perform non-invasive Raman spectroscopy measurements on liposomal doxorubicin. Raman spectroscopy provides chemically specific, potentially quantitative information, with measurements able to be performed on the contents of a sealed glass vial. We developed and validated the method by using a model system of polystyrene (PS) nanospheres and produced calibration curves for the concentration of PS at sizes of 40 nm, 125 nm and 200 nm. We then applied the same method to a liposomal doxorubicin formulation to measure the concentration of lipidic and drug components, and differences in the percentage of encapsulated drug. Our results show that by this method we can measure differences in doxorubicin concentration of 0.25 mg ml<small><sup>−1</sup></small> and distinguish between free and encapsulated doxorubicin down to a minimal relative concentration of 2.3%.</p>","PeriodicalId":101141,"journal":{"name":"RSC Pharmaceutics","volume":" 2","pages":" 279-291"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.rsc.org/en/content/articlepdf/2025/pm/d4pm00238e?page=search","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"RSC Pharmaceutics","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/pm/d4pm00238e","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

With a growing interest towards low batch-volume personalised medicines and continuous manufacturing of pharmaceuticals, the need for robust non-invasive quality control analytical methods is becoming increasingly important. Current methods for the quantification of total and encapsulated drug in a liposomal formulation include reversed-phase high-performance liquid chromatography with ultraviolet or fluorescence spectroscopy, which requires sample consumption after procedures such as ultrafiltration to separate the free drug from the encapsulated drug. We have developed and tested a method to perform non-invasive Raman spectroscopy measurements on liposomal doxorubicin. Raman spectroscopy provides chemically specific, potentially quantitative information, with measurements able to be performed on the contents of a sealed glass vial. We developed and validated the method by using a model system of polystyrene (PS) nanospheres and produced calibration curves for the concentration of PS at sizes of 40 nm, 125 nm and 200 nm. We then applied the same method to a liposomal doxorubicin formulation to measure the concentration of lipidic and drug components, and differences in the percentage of encapsulated drug. Our results show that by this method we can measure differences in doxorubicin concentration of 0.25 mg ml−1 and distinguish between free and encapsulated doxorubicin down to a minimal relative concentration of 2.3%.

Abstract Image

非侵入性定量化学测量脂质体配方使用拉曼光谱†
随着对低批量个性化药品和药品连续生产的兴趣日益增长,对强大的非侵入性质量控制分析方法的需求变得越来越重要。目前用于定量脂质体制剂中总药物和包被药物的方法包括反相高效液相色谱法和紫外或荧光光谱法,这需要在超滤等程序后消耗样品,以分离游离药物和包被药物。我们开发并测试了一种对阿霉素脂质体进行非侵入性拉曼光谱测量的方法。拉曼光谱提供了化学特异性的、潜在的定量信息,可以对密封玻璃小瓶的内容物进行测量。利用聚苯乙烯(PS)纳米球模型系统建立并验证了该方法,并绘制了聚苯乙烯(PS)在40 nm、125 nm和200 nm尺寸下的浓度校准曲线。然后,我们将同样的方法应用于阿霉素脂质体制剂,测量脂质和药物成分的浓度,以及胶囊化药物百分比的差异。我们的结果表明,通过这种方法,我们可以测量0.25 mg ml−1的阿霉素浓度差异,并区分游离和封装阿霉素的最小相对浓度为2.3%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信